BioHarvest Sciences to Host Third Quarter 2024 Earnings Call on November 25 at 4:30 P.M. Eastern Time
BioHarvest Sciences to Host Third Quarter 2024 Earnings Call on November 25 at 4:30 P.M. Eastern Time
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 18, 2024) - BioHarvest Sciences Inc. (NASDAQ: BHST) (CSE: BHSC) (FSE: 8MV) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that it will release financial results for the third quarter ended September 30, 2024 after market close on Monday, November 25, 2024.
温哥华,不列颠哥伦比亚省和以色列雷霍沃特--(新闻稿 corp. - 2024年11月18日) - BioHarvest Sciences Inc. (纳斯达克: BHST) (CSE: BHSC) (FSE: 8MV) ("BioHarvest"或"公司"), 一家引领其专利植物合成技术平台的公司,今天宣布将于2024年11月25日星期一美国股市收盘后公布截至2024年9月30日的第三季度财务业绩。
Management will host an investor conference call at 4:30 p.m. Eastern time on Monday, November 25, 2024, to discuss BioHarvest's third quarter 2024 financial results, provide a corporate update, and conclude with a question-and-answer session from telephone participants. To participate, please use the following information:
管理层将于2024年11月25日星期一美国东部时间下午4:30举行投资者电话看涨会,讨论BioHarvest的2024年第三季度财务业绩,提供公司最新资讯,并最后进行电话参与者提问环节。欲参与,请使用以下资讯:
Third Quarter FY2024 Results Conference Call
Date: Monday, November 25, 2024
Time: 4:30 p.m. Eastern time
U.S./Canada Dial-in: 1-844-825-9789
International Dial-in: 1-412-317-5180
Conference ID: 10194495
Webcast: BHST Q3 FY2024 Earnings Conference Call
2024财年第三季度业绩电话看涨会
日期:2024年11月25日,星期一
时间:东部时间下午4:30
美国/加拿大拨入号码: 1-844-825-9789
国际拨入号码: 1-412-317-5180
会议ID: 10194495
网络直播:BHSt 第三季度2024财年业绩会看涨
Please dial in at least 10 minutes before the start of the call to ensure timely participation.
请提前至少10分钟拨打电话以确保及时参加。
A telephone playback of the call will be available through Monday, December 9, 2024. To listen, call 1-844-512-2921 within the United States and Canada or 1-412-317-6671 when calling internationally, using replay pin number 10194495. A webcast replay will also be available by clicking here: BHST Q3 FY2024 Earnings Conference Call.
通过2024年12月9日星期一,可通过电话重播通话。要收听,请拨打1-844-512-2921(美国和加拿大)或拨打1-412-317-6671(国际通话),使用重放密码10194495。点击此处也可以通过网络直播重播:BHSt 第三季度2024财年业绩会看涨。
About BioHarvest Sciences Inc.
BioHarvest Sciences Inc.简介
BioHarvest Sciences Inc. (NASDAQ: BHST) (CSE: BHSC) (FSE: 8MV) is a leader in Botanical Synthesis, leveraging its patented technology platform to grow plant-based molecules, without the need to grow the underlying plant. BioHarvest is leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two major business verticals; as a contract development and production organization (CDMO) on behalf of customers seeking complex molecules, and as a creator of proprietary nutraceutical health and wellness products, which includes dietary supplements. To learn more, please visit .
BioHarvest Sciences Inc.(纳斯达克:BHST)(cse:BHSC)(FSE:8MV)是植物合成领域的领导者,利用其拥有的专利技术平台种植基于植物的分子,无需种植基础植物。BioHarvest正在利用其植物合成技术开发基于科学的、经过临床验证的下一代治疗解决方案,涵盖两个主要业务垂直领域;作为代表寻求复杂分子的客户的合同开发和生产组织(CDMO),以及作为专有营养保健品健康产品的创造者,包括膳食补充剂。要了解更多,请访问。
Forward-Looking Statements
前瞻性声明
Information set forth in this news release might include forward-looking statements that are based on management's current estimates, beliefs, intentions, and expectations, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. All forward-looking statements are inherently uncertain and actual results may be affected by a number of material factors beyond our control. Readers should not place undue reliance on forward-looking statements. BHSC does not intend to update forward-looking statement disclosures other than through our regular management discussion and analysis disclosures.
本新闻稿中的信息可能包含基于管理层的当前估计、信念、意图和期望而基于的前瞻性声明,且可能受到一系列风险和不确定性的影响,这可能导致实际结果与前瞻性声明中描述的结果有所不同。所有前瞻性声明本质上都是不确定的,实际结果可能会受到我们控制之外的一些实质性因素的影响。读者不应过度依赖前瞻性声明。BHSC无意通过常规管理讨论和分析披露之外的其他方式更新前瞻性声明披露。
Neither the Canadian Securities Exchange nor its Regulation Services Provider accept responsibility for the adequacy or accuracy of this release.
加拿大证券交易所及其规定服务供应商对本声明的充分性或准确性不承担任何责任。
This release has been reviewed and approved by Dave Ryan, VP Investor Relations, who accepts responsibilities for its contents.
此新闻稿内容已由Dave Ryan, VP Investor Relations审核并批准。
BioHarvest Corporate Contact:
Dave Ryan, VP Investor Relations & Director
+1 (604) 622-1186
info@bioharvest.com
BioHarvest的公司联系方式:
Dave Ryan,投资者关系和董事副总裁
+1 (604) 622-1186
info@bioharvest.com
Investor Relations Contact:
Lucas A. Zimmerman
Managing Director
MZ Group - MZ North America
+1 (949) 259-4987
BHSC@mzgroup.us
投资者关系联系人:
Lucas A. Zimmerman
常务董事
MZ Group - MZ North America
+1 (949) 259-4987
BHSC@mzgroup.us